{"id":15317,"date":"2026-06-03T17:01:00","date_gmt":"2026-06-03T15:01:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=ed5be2e003689d75c560769e138f0734"},"modified":"2026-06-03T17:01:00","modified_gmt":"2026-06-03T15:01:00","slug":"quanterix-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=15317","title":{"rendered":"Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference"},"content":{"rendered":"<p>BILLERICA, Mass.--(BUSINESS WIRE)--<b>Quanterix Corporation (Nasdaq: QTRX)<\/b>, a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that senior management will participate in the Goldman Sachs 47<sup>th<\/sup> Annual Global Healthcare Conference being held in Miami, FL from June 8-10, 2026. Chief Executive Officer Everett Cunningham will engage in a fireside chat at 1:20 pm ET on Tuesday, June 9, during which he will provide an update on the Company and its strategic priorities. The Company is also scheduling one-on-one investor meetings at the event.<\/p><p>\n<b>Webcast Information<\/b><\/p><p>\nThe live webcast presentation can be accessed from the <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.quanterix.com%2F&amp;esheet=54546408&amp;newsitemid=20260603495825&amp;lan=en-US&amp;anchor=Investor+Relations&amp;index=1&amp;md5=d1f7d7dfe30daa9941cb5e640f5083a4\" rel=\"nofollow\" shape=\"rect\">Investor Relations<\/a> section of the company\u2019s website at <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.quanterix.com&amp;esheet=54546408&amp;newsitemid=20260603495825&amp;lan=en-US&amp;anchor=www.quanterix.com&amp;index=2&amp;md5=00f76393900315f2031c224d66063604\" rel=\"nofollow\" shape=\"rect\">www.quanterix.com<\/a>. A replay of the webcast will be available following the conference on the website.<\/p><p>\n<b>About Quanterix<\/b><\/p><p>\nQuanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa<sup>\u00ae<\/sup> technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With approximately 6,500 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company<sup>\u00ae<\/sup>, adding multiplexed tissue imaging with single-cell resolution to its portfolio and 1,450 installed instruments. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue\u2014advancing precision medicine from discovery to diagnostics. Learn more at <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.quanterix.com&amp;esheet=54546408&amp;newsitemid=20260603495825&amp;lan=en-US&amp;anchor=www.quanterix.com&amp;index=3&amp;md5=cf8f156c16b183c01d5aa266491fd9f3\" rel=\"nofollow\" shape=\"rect\">www.quanterix.com<\/a>.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\nMedia\n<br\/><a  href=\"mailto:media@quanterix.com\" rel=\"nofollow\" shape=\"rect\">media@quanterix.com<\/a><\/p><p>\nInvestor Relations\n<br\/>Joshua Young\n<br\/><a  href=\"mailto:ir@quanterix.com\" rel=\"nofollow\" shape=\"rect\">ir@quanterix.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>BILLERICA, Mass.&#8211;(BUSINESS WIRE)&#8211;Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that senior management will participate in the Goldman Sac&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-15317","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15317"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15317\/revisions"}],"predecessor-version":[{"id":15318,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/15317\/revisions\/15318"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}